Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

A panelist discusses how bleeding risk assessment depends on platelet count levels (highest risk below 20,000), requiring ...

A panelist discusses how dry eye disease involves tear film imbalance, leading to inflammation and ocular surface damage, ...

Sundar Jagannath, MBBS, highlights long-term follow-up data from the phase 1b/2 CARTITUDE-1 trial, showing durable responses and potential cures with ciltacabtagene autoleucel in patients with ...

The Global Liver Institute urges worldwide integration of liver health into diabetes and obesity care as steatotic liver ...

Initiating fecal immunochemical test (FIT) screening before age 50 can significantly reduce colorectal cancer incidence and ...

Participants with Duchenne muscular dystrophy (DMD) who received RGX-202 demonstrated functional improvement and better ...

Patients with low psoriasis body surface area (BSA) can have similar quality of life impacts and symptom burdens as those ...

Revumenib shows promise for high-risk patients with acute myeloid leukemia (AML) with specific genetic mutations, ...

Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately ...

The timing of immunotherapy initiation is not a significant factor in the outcomes of patients with extensive-stage small ...

Panelists discuss how autologous stem cell transplant remains essential in frontline multiple myeloma management despite improved quadruple therapy outcomes, emphasizing that current evidence still ...